HOME >> BIOLOGY >> NEWS
Combating blindness is vision of UT, ORNL project

OAK RIDGE, Tenn., Feb. 9, 2005 Millions of people at risk of becoming blind could one day be helped by an Oak Ridge National Laboratory technology originally intended to understand semiconductor defects.

The project takes advantage of the Department of Energy lab's proprietary content-based image retrieval technology, which is a method for sorting and finding visually similar images in large databases. Manufacturers of semiconductors have found this technology highly effective for rapidly scanning hundreds of thousands of tiny semiconductors to learn quickly about problems with manufacturing processes.

"We're adapting a proven technology and combining it with new image gathering and analysis tools to help create a database to assist in the diagnosis and treatment of blinding eye diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration," said project co-leader Ken Tobin of ORNL's Engineering Science & Technology Division.

Diabetic retinopathy alone will affect 239 million people worldwide by 2010, according to Tobin, who noted that this number will have doubled since 1994.

Partnering with ORNL is Edward Chaum, an ophthalmologist and Plough Foundation professor of retinal diseases at the University of Tennessee Health Science Center in Memphis.

Researchers plan to use digital retinal photography and optical coherence tomography -- a technique for examining living tissue non-invasively -- to image and quantify specific disease-based changes in the retina. They will develop an extensive image database of known retinal disease states for clinical validation studies.

Institutional Review Board approval was secured to enable Tobin and ORNL colleagues Tom Karnowski and Priya Govindasamy to assemble a database of thousands of fluorescein angiography and optical coherence tomography images representing hundreds of diagnosed human patients and retinal diseases.

"The dataset provided by Dr. Cha
'"/>

Contact: Ron Walli
wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory
9-Feb-2005


Page: 1 2

Related biology news :

1. Combating anthrax: Results of study published this month as researchers look for a better vaccine
2. Combating antibiotic resistance
3. Research team enlightens the reasons for severe blindness
4. Study identifies new gene therapy tools for inherited blindness
5. Gene variant increases risk of blindness
6. Penn researchers report that gene therapy awakens the brain despite blindness from birth
7. Lucky 13 as new gene discovery offers further hope for childhood blindness
8. Gene therapy for blindness clears hurdle in mice
9. Transport interrupted -- Texas A&M biologists trace cause of early blindness to tissue defect
10. Gene therapy for inherited childhood blindness tested in mice
11. Gene therapy for chicken model of childhood blindness

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
Breaking Biology Technology:
Cached News: